欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 神经科学类
神经科学类

Anti-disialoganglioside 2 mAbs

简要描述:

7A4 binds to GD2: GD2+ neuroblastoma cell lines and melanomas, small-cell lung carcinomas, rhabdomyosarcomas, Ewings sarcomas, Wilm‘s tumors and retinoblastomas also expressing GD2. GD2- cell lines or GD2- peripheral blood cells are not bound by the antibody. The antibody and the scFv cross-react weakly with GD3 and GM2. GD2 is a target for tumor therapy due to its high level of expression in the majority of neuroblastoma and melanoma cells, and poor levels of expression in normal tissues.

产品参数:

Cat. No.:MABL-039

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:Depletion, RIA, TLC, ELISA, IF, IHC

详细介绍

Key features and details

Cat. No.

MABL-039

Name

Anti-disialoganglioside 2 mAbs

Clone No.

AFD-7A4

From

Recombinant Antibody

Isotype

Engineer antibody

Application

 Depletion, RIA, TLC, ELISA, IF, IHC

Species Reactivity

Human

Basic Information

Specificity

7A4 binds to GD2: GD2+ neuroblastoma   cell lines and melanomas, small-cell lung carcinomas, rhabdomyosarcomas,   Ewings sarcomas, Wilm's tumors and retinoblastomas also expressing GD2. GD2-   cell lines or GD2- peripheral blood cells are not bound by the antibody. The   antibody and the scFv cross-react weakly with GD3 and GM2. GD2 is a target   for tumor therapy due to its high level of expression in the majority of   neuroblastoma and melanoma cells, and poor levels of expression in normal   tissues.

Alternative Name

GD2

UniProt


Immunogen

7A4 was generated by hyperimmunizing   mice with recombinant gamma-interferon-treated LAN-1 neuroblastoma cells.

Application Notes

7A4 is able to lyse tumour cells by   complement-mediated cytotoxicity (lytic dose ~10 ng) and can perform in vitro   direct binding of labelled mAb to living and glutaraldehyde-fixed cells.   Shows strong binding to all neuroblastomas tested in addition to other   GD2-expressing cells such as melanomas, small-cell lung carcinomas,   rhabdomyosarcomas, Ewings sarcomas, Wilm's tumors and retinoblastomas.TLC   analysis can be used to confirm the antibody target antigen. The 7A4 scFv   possesses the same specificity as the full-length antibody but slightly   weaker binding affinity. The scFv has been used in IF studies (PMID:   9309424).

Antibody First Published

Gross et al. New anti-GD2 monoclonal   antibodies produced from gamma- interferon-treated neuroblastoma cells   International journal of cancer, 15 April 1989, Vol.43(4), pp.665-71   PMID:2467885

Note on publication

Describes the characterization of   7A4 and other anti-neuroblastoma antibodies by TLC, IHC, in vitro direct   binding, complement-cytotoxicity assays and solid phase RIA.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.

 


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-Crotoxin mAbs

下一篇: Anti-CD40L mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号